23-LEUK-22-GS: GS-US-546-5857, Enhance-2_A Phase 3, Randomized, Open-Label Study Evaluating the Safety and Efficacy of Magrolimab in Combination with Azacitidine versus Physician s Choice of Venetoclax in Combination with Azacitidine or Intensive Chemothe

Grants and Contracts Details

StatusActive
Effective start/end date6/27/236/27/25

Funding

  • Gilead Sciences Inc: $22,934.00